To safeguard the health and well-being of our entire community, let’s approach the challenges of this semester together. All members of the MIT community who come to campus must follow the guidance and processes outlined in Health & Testing and Campus Access.

Recent updates

Quick links

Current status

As of October 14, 2020, MIT transitioned into Phase 3 of the Research Ramp-Up (RR3) for laboratory research. Under RR3, the cap on the aggregate number of hours laboratory personnel may work on campus has been lifted; however, the maximum personnel density requirement of 125 sf/person as well as the physical distancing requirement of at least 6 feet of separation in static work conditions remain. All other guidelines related to Covid-19-era safety and other practices that were in place during Research Ramp-Up 2 (RR2) remain in place:

  • Guidance for office space use at up to 50 percent capacity, which was released on August 18, has not changed. (See Office and meeting space limits extended – temporarily revised limits ending February 8, 2021).
  • It is recommended that all activities of laboratory-based research groups that can be successfully performed remotely, including one-on-one meetings and group meetings, should be conducted remotely.
  • Every MIT staff member who can work successfully from home will need to continue doing so.

All plans to use laboratory or office space, or to get access to offices to pick up materials, must be approved by the DLC. For detailed guidance and planning information, see MIT Research Ramp-Up information.

Access to campus buildings during the research ramp-up is controlled by Covid Pass via the Covid Access System, both part of MIT’s Covid-19 Response System (MCRS).

Researchers are reminded that work with nucleic acids encoding for any portion of the SARS-CoV-2 genome may not begin without approval from the MIT Committee on Assessment of Biohazards & Embryonic Stem Cell Research Oversight (CAB/ESCRO) (MIT certificate required). Consult your biosafety officer for more information. If you are planning to work with the SARS-CoV-2 N gene (Nucleocapsid), please review the guidance document for amplifying the SARS-CoV-2 N gene (MIT certificate required).

Guidance to restart direct person-to-person human subject research was released on September 11, 2020. All requests to restart human subject research must be submitted through COUHES Connect and must be approved by COUHES before restarting. Please note that COUHES approval is necessary but not sufficient for the resumption of human subject research; additional policies may also apply.

In order to maintain low building density and to allow faculty, staff, postdocs, and students to have increased capacity to campus as safely as possible, visitor access to campus will be significantly limited and discouraged through spring semester 2021. See the research visitor guidelines for the latest information.

MIT has extended the suspension of MIT-related international travel for students, faculty, postdocs, and staff until further notice. MIT-related domestic travel also remains suspended for most travelers. See the MIT travel policy for more information.